Emma McBryde
Emma McBryde
Australian Institute of Tropical Health and Medicine, James Cook University
Bestätigte E-Mail-Adresse bei jcu.edu.au - Startseite
Zitiert von
Zitiert von
Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study
CCH Murdoch DR, Corey GR, Hoen B, Miró JM, Fowler VG Jr, Bayer AS, Karchmer ...
Arch Int Med 169 (5), 463-73, 2009
Current features of infective endocarditis in elderly patients: results of the International Collaboration on Endocarditis Prospective Cohort Study
UR Durante-Mangoni E, Bradley S, Selton-Suty C, Tripodi MF, Barsic B, Bouza ...
Arch Int Med 168 (19), 2095-2103, 2008
Health care-associated native valve endocarditis: importance of non-nosocomial acquisition
PD Natividad Benito, MD, PD José M. Miró, MD, MS Elisa de Lazzari, ...
Annals of Internal Medicine 150 (9), 586-594, 2009
An investigation of contact transmission of methicillin-resistant Staphylococcus aureus
ES McBryde, LC Bradley, M Whitby, DLS McElwain
Journal of Hospital Infection 58 (2), 104-108, 2004
Low serum mannose-binding lectin level increases the risk of death due to pneumococcal infection
DP Eisen, MM Dean, MA Boermeester, KJ Fidler, AC Gordon, G Kronborg, ...
Clinical Infectious Diseases 47 (4), 510-516, 2008
The impact of injecting networks on hepatitis C transmission and treatment in people who inject drugs
M Hellard, DA Rolls, R Sacks‐Davis, G Robins, P Pattison, P Higgs, ...
Hepatology 60 (6), 1861-1870, 2014
A stochastic mathematical model of methicillin resistant Staphylococcus aureus transmission in an intensive care unit: Predicting the impact of interventions
ES McBryde, AN Pettitt, DLS McElwain
Journal of theoretical biology 245 (3), 470-481, 2007
Treatment scale-up to achieve global HCV incidence and mortality elimination targets: a cost-effectiveness model
N Scott, ES McBryde, A Thompson, JS Doyle, ME Hellard
Gut 66 (8), 1507-1515, 2017
Construction of a mathematical model for tuberculosis transmission in highly endemic regions of the Asia-Pacific
JM Trauer, JT Denholm, ES McBryde
Journal of theoretical biology 358, 74-84, 2014
Feasibility of achieving the 2025 WHO global tuberculosis targets in South Africa, China, and India: a combined analysis of 11 mathematical models
RMGJ Houben, NA Menzies, T Sumner, GH Huynh, N Arinaminpathy, ...
The Lancet Global Health 4 (11), e806-e815, 2016
Acetyl salicylic acid usage and mortality in critically ill patients with the systemic inflammatory response syndrome and sepsis
DP Eisen, D Reid, ES McBryde
Critical care medicine 40 (6), 1761-1767, 2012
A biological model for influenza transmission: pandemic planning implications of asymptomatic infection and immunity
JD Mathews, CT McCaw, J McVernon, ES McBryde, JM McCaw
PLoS One 2 (11), e1220, 2007
An alternative scoring system to predict risk for surgical site infection complicating coronary artery bypass graft surgery
ND Friedman, AL Bull, PL Russo, K Leder, C Reid, B Billah, S Marasco, ...
Infection Control & Hospital Epidemiology 28 (10), 1162-1168, 2007
Early transmission characteristics of influenza A (H1N1) v in Australia: Victorian state, 16 May–3 June 2009
ES McBryde, I Bergeri, C van Gemert, J Rotty, EJ Headley, K Simpson, ...
Eurosurveillance 14 (42), 19363, 2009
Studies needed to address public health challenges of the 2009 H1N1 influenza pandemic: insights from modeling
MD Van Kerkhove, T Asikainen, NG Becker, S Bjorge, JC Desenclos, ...
PLoS Med 7 (6), e1000275, 2010
Eradication of hepatitis C infection: the importance of targeting people who inject drugs
M Hellard, JS Doyle, R Sacks‐Davis, AJ Thompson, E McBryde
Hepatology 59 (2), 366-369, 2014
Mannose‐binding lectin and susceptibility to tuberculosis: a meta‐analysis
JT Denholm, ES McBryde, DP Eisen
Clinical & Experimental Immunology 162 (1), 84-90, 2010
Quality of drug interaction alerts in prescribing and dispensing software
M Sweidan, JF Reeve, JE Brien, P Jayasuriya, JH Martin, GM Vernon
Medical journal of Australia 190 (5), 251-254, 2009
Risk of active tuberculosis in the five years following infection... 15%?
JM Trauer, N Moyo, EL Tay, K Dale, R Ragonnet, ES McBryde, ...
Chest 149 (2), 516-525, 2016
Meropenem versus piperacillin-tazobactam for definitive treatment of bloodstream infections due to ceftriaxone non-susceptible Escherichia coli and Klebsiella spp (the MERINO …
PNA Harris, AY Peleg, J Iredell, PR Ingram, S Miyakis, AJ Stewardson, ...
Trials 16 (1), 1-8, 2015
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20